ClassID:

96124

C07F9/62 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom; Six-membered rings Isoquinoline or hydrogenated isoquinoline ring systems

Recent Application in this class:
#1
20260125346
2026-05-07

Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of Disease

#2
20250367188
2025-12-04

COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

#3
20250129028
2025-04-24

COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR

#4
20240366590
2024-11-07

COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

#5
20230112086
2023-04-13

Photo-cleavable primer compositions and methods of use

#6
20230103027
2023-03-30

Surface primer compositions and methods of use

#7
20230031776
2023-02-02

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

#8
20220331346
2022-10-20

Substituted bicyclic compounds

#9
20200347248
2020-11-05

Photo-cleavable primer compositions and methods of use

#10
20200347247
2020-11-05

Surface primer compositions and methods of use

#11
20200281952
2020-09-10

Substituted bicyclic compounds

#12
20200268741
2020-08-27

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

#13
20190076450
2019-03-14

Substituted bicyclic compounds

#14
20180222931
2018-08-09

STAT6 inhibitors

#15
20170304332
2017-10-26

Substituted bicyclic compounds

#16
20170217999
2017-08-03

Surface primer compositions and methods of use

#17
20170217997
2017-08-03

Photo-cleavable primer compositions and methods of use

#18
20170042917
2017-02-16

Substituted bicyclic compounds

#19
20160264549
2016-09-15

Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)

#20
20160246152
2016-08-25

Organic compound, electrochromic element containing the same, optical filter, lens unit, imaging device, and window component

#21
20160145279
2016-05-26

STAT6 inhibitors

#22
20160052888
2016-02-25

Substituted bicyclic compounds

#23
20150194617
2015-07-09

Copper complexes for optoelectronic applications

#24
20150158895
2015-06-11

Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)

#25
20130131018
2013-05-23

SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS

#26
20130065857
2013-03-14

NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY

#27
20120283216
2012-11-08

FUNGICIDAL 2-(BICYCLIC ARYLOXY)CARBOXAMIDES

#28
20120184738
2012-07-19

Copper complexes for optoelectronic applications

#29
20120041203
2012-02-16

METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM

#30
20100316676
2010-12-16

Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases

#31
20090306390
2009-12-10

Chiral ligands, their preparation and uses thereof in asymmetric reactions

#32
20090099133
2009-04-16

Isoquinolines Derivatives as Igf-1R Inhibitors

#33
20090036409
2009-02-05

Novel inhibitors of chymase

#34
20080318906
2008-12-25

Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases

#35
20060079487
2006-04-13

Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases

#36
20050176769
2005-08-11

Inhibitors of chymase